Logo image of PRSO

PERASO INC (PRSO) Stock Fundamental Analysis

NASDAQ:PRSO - Nasdaq - US71360T2006 - Common Stock - Currency: USD

0.94  -0.05 (-5.05%)

Fundamental Rating

3

Taking everything into account, PRSO scores 3 out of 10 in our fundamental rating. PRSO was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. While PRSO seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, PRSO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

PRSO had negative earnings in the past year.
PRSO had a negative operating cash flow in the past year.
PRSO had negative earnings in each of the past 5 years.
In the past 5 years PRSO always reported negative operating cash flow.
PRSO Yearly Net Income VS EBIT VS OCF VS FCFPRSO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -148.88%, PRSO is doing worse than 97.27% of the companies in the same industry.
The Return On Equity of PRSO (-309.52%) is worse than 91.82% of its industry peers.
Industry RankSector Rank
ROA -148.88%
ROE -309.52%
ROIC N/A
ROA(3y)-149.9%
ROA(5y)-104.55%
ROE(3y)-311.07%
ROE(5y)-220.29%
ROIC(3y)N/A
ROIC(5y)N/A
PRSO Yearly ROA, ROE, ROICPRSO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

PRSO has a better Gross Margin (51.69%) than 67.27% of its industry peers.
In the last couple of years the Gross Margin of PRSO has declined.
PRSO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.81%
GM growth 5Y-3.27%
PRSO Yearly Profit, Operating, Gross MarginsPRSO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

5

2. Health

2.1 Basic Checks

PRSO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PRSO has been increased compared to 1 year ago.
PRSO has more shares outstanding than it did 5 years ago.
There is no outstanding debt for PRSO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PRSO Yearly Shares OutstandingPRSO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
PRSO Yearly Total Debt VS Total AssetsPRSO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

PRSO has an Altman-Z score of -35.89. This is a bad value and indicates that PRSO is not financially healthy and even has some risk of bankruptcy.
PRSO has a Altman-Z score of -35.89. This is amonst the worse of the industry: PRSO underperforms 88.18% of its industry peers.
PRSO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -35.89
ROIC/WACCN/A
WACC11.24%
PRSO Yearly LT Debt VS Equity VS FCFPRSO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 1.80 indicates that PRSO should not have too much problems paying its short term obligations.
PRSO has a worse Current ratio (1.80) than 79.09% of its industry peers.
PRSO has a Quick Ratio of 1.20. This is a normal value and indicates that PRSO is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.20, PRSO is not doing good in the industry: 80.91% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.2
PRSO Yearly Current Assets VS Current LiabilitesPRSO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 90.92% over the past year.
The Revenue has been growing slightly by 5.99% in the past year.
Measured over the past years, PRSO shows a small growth in Revenue. The Revenue has been growing by 7.64% on average per year.
EPS 1Y (TTM)90.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.36%
Revenue 1Y (TTM)5.99%
Revenue growth 3Y36.91%
Revenue growth 5Y7.64%
Sales Q2Q%37.39%

3.2 Future

PRSO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.42% yearly.
Based on estimates for the next years, PRSO will show a small growth in Revenue. The Revenue will grow by 7.63% on average per year.
EPS Next Y45.72%
EPS Next 2Y35.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.55%
Revenue Next 2Y17.28%
Revenue Next 3Y7.63%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
PRSO Yearly Revenue VS EstimatesPRSO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
PRSO Yearly EPS VS EstimatesPRSO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 0 -1K -2K -3K -4K

1

4. Valuation

4.1 Price/Earnings Ratio

PRSO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PRSO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PRSO Price Earnings VS Forward Price EarningsPRSO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PRSO Per share dataPRSO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PRSO's earnings are expected to grow with 35.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.42%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PRSO!.
Industry RankSector Rank
Dividend Yield N/A

PERASO INC

NASDAQ:PRSO (5/29/2025, 12:19:26 PM)

0.94

-0.05 (-5.05%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-11 2025-08-11/amc
Inst Owners12.77%
Inst Owner Change37.16%
Ins Owners3.29%
Ins Owner Change0.84%
Market Cap4.73M
Analysts85
Price Target3.35 (256.38%)
Short Float %1.21%
Short Ratio0.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.01%
Min EPS beat(2)-41.84%
Max EPS beat(2)37.83%
EPS beat(4)2
Avg EPS beat(4)-25.45%
Min EPS beat(4)-136.37%
Max EPS beat(4)38.59%
EPS beat(8)4
Avg EPS beat(8)-21.9%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.11%
Min Revenue beat(2)-6.79%
Max Revenue beat(2)-5.43%
Revenue beat(4)1
Avg Revenue beat(4)-3.56%
Min Revenue beat(4)-6.79%
Max Revenue beat(4)0.11%
Revenue beat(8)4
Avg Revenue beat(8)-0.02%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)46.67%
EPS NY rev (1m)2.11%
EPS NY rev (3m)-28.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)12.72%
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)-1.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.32
P/FCF N/A
P/OCF N/A
P/B 1.36
P/tB 1.37
EV/EBITDA N/A
EPS(TTM)-1.43
EYN/A
EPS(NY)-0.36
Fwd EYN/A
FCF(TTM)-0.91
FCFYN/A
OCF(TTM)-0.91
OCFYN/A
SpS2.9
BVpS0.69
TBVpS0.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -148.88%
ROE -309.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.69%
FCFM N/A
ROA(3y)-149.9%
ROA(5y)-104.55%
ROE(3y)-311.07%
ROE(5y)-220.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.81%
GM growth 5Y-3.27%
F-Score6
Asset Turnover2.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.8
Quick Ratio 1.2
Altman-Z -35.89
F-Score6
WACC11.24%
ROIC/WACCN/A
Cap/Depr(3y)11.82%
Cap/Depr(5y)21.25%
Cap/Sales(3y)2.49%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.36%
EPS Next Y45.72%
EPS Next 2Y35.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.99%
Revenue growth 3Y36.91%
Revenue growth 5Y7.64%
Sales Q2Q%37.39%
Revenue Next Year0.55%
Revenue Next 2Y17.28%
Revenue Next 3Y7.63%
Revenue Next 5YN/A
EBIT growth 1Y50.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year47.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2.37%
OCF growth 3YN/A
OCF growth 5YN/A